TG Therapeutics Inc - Company Profile

Powered by

All the sales intelligence you need on TG Therapeutics Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how TG Therapeutics Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with TG Therapeutics Inc.

Back to companies

TG Therapeutics Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on TG Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into TG Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Michael S. Weiss

Chairman; Chief Executive Officer; President Executive Board Since: 2011 Age: 60

Mr. Michael S. Weiss has been the Chairman, President, and Chief Executive Officer of the company since 2011. Prior to this, he served as the Co-founder, Managing Partner, and Principal of Opus Point Partners since 2008. Mr. Weiss also served as the Director and Chairman of National Holdings Corporation.

Read Hide full bio of Michael S. Weiss

Sean A. Power

Chief Financial Officer Senior Management Since: 2011 Age: 44

Mr. Sean A. Power has been the Chief Financial Officer of the company since 2011. Prior to this, he served as the Corporate Controller at Keryx Biopharmaceuticals, Inc. Mr. Power also served as the independent certified public accountant with KPMG, LLP and Chief Financial Officer of Opus Point Partners.

Read Hide full bio of Sean A. Power

Adam Waldman

Chief Commercial Officer Senior Management Since: 2018

Mr. Adam Waldman has been the Chief Commercial Officer of the company since 2018. Prior to this, he served as the Head of US Hematology-Oncology Marketing at Celgene Corporation. Previously, he served as the Senior Product Manager at Schering-Plough.

Read Hide full bio of Adam Waldman

Kenneth Hoberman

Director Non Executive Board Since: 2014 Age: 60

Yann Echelard, Ph.D.

Director Non Executive Board Since: 2012 Age: 62
Gain a 360-degree view of TG Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of TG Therapeutics Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer